These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1508692)

  • 21. Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene.
    Liang H; Lunec J
    Gene; 2005 Nov; 361():112-8. PubMed ID: 16202543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative regulation of Rb expression by the p53 gene product.
    Shiio Y; Yamamoto T; Yamaguchi N
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5206-10. PubMed ID: 1608930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of c-fos expression in the butyrate-induced F-98 glioma cell differentiation.
    Tang SJ; Huang YM; Wang FF
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):47-56. PubMed ID: 7864828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INI1/hSNF5/BAF47 represses c-fos transcription via a histone deacetylase-dependent manner.
    Pan X; Zhai L; Sun R; Li X; Zeng X
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1052-8. PubMed ID: 16219292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wild-type p53 can down-modulate the activity of various promoters.
    Ginsberg D; Mechta F; Yaniv M; Oren M
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9979-83. PubMed ID: 1946467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary characterisation of mechanoresponsive regions of the c-fos promoter in bone cells.
    Peake MA; El Haj AJ
    FEBS Lett; 2003 Feb; 537(1-3):117-20. PubMed ID: 12606042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter.
    Osifchin NE; Jiang D; Ohtani-Fujita N; Fujita T; Carroza M; Kim SJ; Sakai T; Robbins PD
    J Biol Chem; 1994 Mar; 269(9):6383-9. PubMed ID: 8119988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene.
    Buttice G; Quinones S; Kurkinen M
    Nucleic Acids Res; 1991 Jul; 19(13):3723-31. PubMed ID: 1906606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max.
    Kirch HC; Flaswinkel S; Rumpf H; Brockmann D; Esche H
    Oncogene; 1999 Apr; 18(17):2728-38. PubMed ID: 10348347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Restrictive Suicide Gene Therapy for Glioma Controlled by the FOS Promoter.
    Pan J; Wang H; Liu X; Hu J; Song W; Luo J; Jiang S; Yan F; Zhai B
    PLoS One; 2015; 10(11):e0143112. PubMed ID: 26571389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overlapping domains on the p53 protein regulate its transcriptional activation and repression functions.
    Subler MA; Martin DW; Deb S
    Oncogene; 1994 May; 9(5):1351-9. PubMed ID: 8152795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phorbol ester inhibition of rat gonadotropin-releasing hormone promoter activity: role of Fos and Jun in the repression of transcription.
    Bruder JM; Spaulding AJ; Wierman ME
    Mol Endocrinol; 1996 Jan; 10(1):35-44. PubMed ID: 8838143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.
    Sugars KL; Budhram-Mahadeo V; Packham G; Latchman DS
    Nucleic Acids Res; 2001 Nov; 29(22):4530-40. PubMed ID: 11713302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells.
    Li C; Ahlborn TE; Tokita K; Boxer LM; Noda A; Liu J
    Oncogene; 2001 Dec; 20(57):8193-202. PubMed ID: 11781835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor.
    Weisz A; Rosales R
    Nucleic Acids Res; 1990 Sep; 18(17):5097-106. PubMed ID: 2119495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.
    Wu YH; Tsai Chang JH; Cheng YW; Wu TC; Chen CY; Lee H
    Oncogene; 2007 Jul; 26(33):4761-73. PubMed ID: 17325666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53-mediated transcription induces resistance of DNA to UV inactivation.
    Huang J; Logsdon N; Schmieg FI; Simmons DT
    Oncogene; 1998 Jul; 17(4):401-11. PubMed ID: 9696032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteocalcin gene expression is regulated by wild-type p53.
    Chen H; Hays E; Liboon J; Neely C; Kolman K; Chandar N
    Calcif Tissue Int; 2011 Nov; 89(5):411-8. PubMed ID: 21964930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
    Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
    Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.